Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis

BACKGROUND: Real-world analyses of treatments for patients with metastatic breast cancer are limited. We evaluated the comparative effectiveness of nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer using data from an electronic medical record database from community practices a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahtani, Reshma L, Parisi, Monika, Glück, Stefan, Ni, Quanhong, Park, Siyeon, Pelletier, Corey, Faria, Claudio, Braiteh, Fadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808700/
https://www.ncbi.nlm.nih.gov/pubmed/29445301
http://dx.doi.org/10.2147/CMAR.S150960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808700/
https://www.ncbi.nlm.nih.gov/pubmed/29445301
http://dx.doi.org/10.2147/CMAR.S150960

Ejemplares similares